Biotage Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
17 Jul 24 | BuySEK 575,072 | Scott Carr | Individual | 2,973 | SEK 193.43 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 455,854 | 0.569% |
Private Companies | 13,590,648 | 17% |
General Public | 16,940,363 | 21.2% |
Institutions | 49,062,407 | 61.3% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,946,867 | SEK 1.9b | 0% | no data | |||
6,365,330 | SEK 1.0b | 175% | 0.91% | |||
4,675,806 | SEK 742.5m | 0.71% | 0.13% | |||
3,900,000 | SEK 619.3m | 0% | 0.21% | |||
3,808,712 | SEK 604.8m | 0% | 0.01% | |||
3,400,219 | SEK 540.0m | 0% | 0.07% | |||
2,787,400 | SEK 442.6m | 0% | no data | |||
2,769,095 | SEK 439.7m | 0% | 0.17% | |||
2,616,783 | SEK 415.5m | 0% | 0.02% | |||
2,246,762 | SEK 356.8m | 0% | 0.14% | |||
2,207,932 | SEK 350.6m | 1,040% | no data | |||
2,086,000 | SEK 331.3m | -0.02% | no data | |||
1,643,781 | SEK 261.0m | 0% | no data | |||
972,839 | SEK 154.5m | 0% | 0.08% | |||
965,974 | SEK 153.4m | -2.08% | no data | |||
710,000 | SEK 112.7m | 0% | 0.04% | |||
621,539 | SEK 98.7m | -8.54% | no data | |||
615,805 | SEK 97.8m | 0% | 0.31% | |||
529,280 | SEK 84.0m | 0% | 1.64% | |||
481,838 | SEK 76.5m | -0.15% | no data | |||
472,801 | SEK 75.1m | 0% | 0.02% | |||
444,536 | SEK 70.6m | 0% | 2.3% | |||
427,300 | SEK 67.9m | 0% | 0.33% | |||
419,277 | SEK 66.6m | 0% | 2.45% | |||
412,873 | SEK 65.6m | 0% | 0.02% |
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/18 01:52 |
End of Day Share Price | 2024/12/18 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Biotage AB (publ) is covered by 7 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Samuel England | Berenberg |
Odysseas Manesiotis | Berenberg |
Marcus Bellander | Carnegie Investment Bank AB |